Convalescent plasma for people with COVID-19: a living systematic review-Reference-Cited by-同舟云学术

Convalescent plasma for people with COVID-19: a living systematic review

Published:2023-02-01 Issue:2 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Iannizzi Claire¹,Chai Khai Li²,Piechotta Vanessa³,Valk Sarah J⁴⁵,Kimber Catherine⁶,Monsef Ina³,Wood Erica M²,Lamikanra Abigail A⁷,Roberts David J⁶,McQuilten Zoe²,So-Osman Cynthia⁸⁹,Jindal Aikaj¹⁰,Cryns Nora¹,Estcourt Lise J¹¹,Kreuzberger Nina³,Skoetz Nicole³

Affiliation:

1. Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne; University of Cologne; Cologne Germany

2. Transfusion Research Unit, School of Public Health and Preventive Medicine; Monash University; Melbourne Australia

3. Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

4. Jon J van Rood Center for Clinical Transfusion Research; Sanquin/Leiden University Medical Center; Leiden Netherlands

5. Department of Clinical Epidemiology; Leiden University Medical Center; Leiden Netherlands

6. Systematic Review Initiative; NHS Blood and Transplant; Oxford UK

7. Clinical, Research and Development; NHS Blood and Transplant; Oxford UK

8. Sanquin Blood Bank; Amsterdam Netherlands

9. Erasmus Medical Centre; Rotterdam Netherlands

10. Department of Transfusion Medicine; SPS Hospitals; Ludhiana (Punjab) India

11. Haematology/Transfusion Medicine; NHS Blood and Transplant; Oxford UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference471 articles.

1. Convalescent plasma in the management of moderate COVID-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID trial);Agarwal;BMJ,2020

2. Convalescent plasma in the management of moderate COVID-19 in India: an open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial);Mukherjee;medRxiv [Preprint],2020

3. Erratum: Convalescent plasma in the management of moderate COVID-19 in adults in India: Open label phase II multicentre randomised controlled trial (PLACID Trial) (The BMJ (2020) 371 (m3939) DOI: 10.1136/bmj.m3939);Agarwal;The BMJ,2020

4. High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial;Alemany;Lancet Respiratory Medicine,2022

5. Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease;AlQahtani;MedRxiv [Preprint],2020

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of antibody-dependent enhancement of infectious disease;Nature Reviews Immunology;2024-08-09

2. COVID-19: A case for plasma derived natural anticoagulants?;Biologicals;2024-08

3. Plasma for prevention and treatment of glycocalyx degradation in trauma and sepsis;Critical Care;2024-07-20

4. Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2;2024-07-16

5. Reduction in ACE2 expression in peripheral blood mononuclear cells during COVID-19 – implications for post COVID-19 conditions;BMC Infectious Diseases;2024-07-03